Bionano Genomics (BNGO) Shares Outstanding (Diluted Average) (2020 - 2026)

Bionano Genomics has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $11.0 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $11.0 million, up 307.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.0 million (up 307.54% YoY), and the FY2025 annual result was $5.4 million, up 328.4% from the prior year.
• Shares Outstanding (Diluted Average) came in at $11.0 million for Q1 2026 at Bionano Genomics, up from $5.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $284.6 million in Q1 2022 to a low of $569000.0 in Q4 2023.
• The 5-year median for Shares Outstanding (Diluted Average) is $5.4 million (2025), against an average of $29.4 million.
• Across the five-year window, Shares Outstanding (Diluted Average) plunged 98.03% in 2023 and soared 365.79% in 2025, its largest moves.
• Bionano Genomics' Shares Outstanding (Diluted Average) stood at $28.9 million in 2022, then slumped by 98.03% to $569000.0 in 2023, then soared by 123.37% to $1.3 million in 2024, then soared by 328.4% to $5.4 million in 2025, then surged by 101.63% to $11.0 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $11.0 million (Q1 2026), $5.4 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.